The board of directors appointed Ming Zhou as a director on October 8, 2026. In connection with the appointment, Chief Executive Officer Shuang Liu gifted 20,000,000 shares of common stock to Ms. Zhou, representing approximately 20.2% of the issued and outstanding shares. The board now consists of four directors: Shuang Liu, Yang Lee, Hua Xie, and Ming Zhou. Goldenwell Biotech operates in the biotechnology sector.
